Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LC-OCT Visualization of Topical Zoryve in Healthy Skin
NCT06440473Phase 4Recruiting
- Sponsor
- Rao Dermatology
- Start
- May 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of roflumilast in plaque psoriasis (2 arms), sponsored by Rao Dermatology. Primary endpoint: Visual qualitative analysis of LC-OCT images at 14 days. Started May 2024; status: recruiting.
02
Drugs
roflumilast
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06440473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06440473.